Literatur
-
1
Kolenda K -D.
Sekundärprävention der koronaren Herzerkrankung.
Dtsch Med Wochenschr.
2003;
128
1849-1853
-
2
Scandinavian Simvastatin Study Group .
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study.
Lancet.
1994;
344
1383-1389
-
3
Antiplatelet Trialists Collaboration .
Collaborative overview of randomised trials of antiplatelet therapy. I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients.
BMJ.
1994;
308
81-106
-
4
Yusuf S, Hawken S, Ounpuu S. et al .
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.
Lancet.
2004;
364
937-952
-
5
Sellmayer a. et al .
Stellenwert von Omega-3-Fettsäuren in der kardiovaskulären Prävention.
Dtsch Med Wochenschr.
2004;
129
1993-1996
Prof. Dr. med. Alois Sellmayer
Dr. med. Rainer Schrepf
Medizinische Poliklinik - Innenstadt, Klinikum der Universität München
Ziemssenstraße 1
80336 München
Phone: ++49/89/51602305
Fax: ++49/89/51604901
Email: alois.sellmayer@med.uni-muenchen.de
